Extract

This is a phase III European multicenter, open label, prospective study to assess the diagnostic accuracy of the use of SonoVue contrast agent to guide prostate biopsies in comparison with the current practice of ultrasound guided systematic biopsy. The trial will involve 15-20 European Centers.

Inclusion criteria

• Prostate cancer

Country

• Austria
• Belgium
• France
• Germany
• Italy
• Netherlands
• United Kingdom

Links

• nct
• ictrp